ZOETIS INC.
NYSE: ZTS
▲
166.00
+2.99
+1.83%
1 Day
-
Open
162.90
-
Previous Close
163.01
-
Volume (Avg)
2.13M (2.19M)
-
Day's Range
161.61-166.19
-
52Wk Range
124.15-187.82
-
Market Cap.
76.71B
-
Dividend Rate (Yield)
1.50 (0.92%)
-
Beta
0.77
-
Shares Outstanding
462.11M
-
P/E Ratio (EPS)
36.82 (4.43)
Top Stories
-
Atlantic Equities Reiterates Zoetis Inc - (ZTS) Overweight Recommendation
Fintel 6 days ago -
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,000 Today
Benzinga -
K-State veterinary medicine professor receives fifth distinguished teacher award
Topeka WIBW-TV -
K-State professor receives excellence award from College of Veterinary Medicine
Topeka WIBW-TV -
Zoetis to Participate in the Stifel 2023 Jaws and Paws Conference
YAHOO!Finance 2 days ago -
Zoetis Inc. (ZTS) Stock: A Closer Look at the Analyst Ratings
newsheater -
Zoetis Declares New Dividend, Hinting At Undervaluation
Mena FN -
Zoetis Holds Investor Day and Presents Strategy to Shape Animal Health for the Next Decade
newsroom.businesswire.com -
Merck Animal Health Expands in Brazil in Quest to Overtake Zoetis as World Animal Health Leader
TheStreet.com -
Zoetis' Dividend Growth: Small Yield, Big Returns
Seeking Alpha -
Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards?
Nasdaq -
Zoetis Shares Are Barking Up the Right Tree
TheStreet.com -
Zoetis CEO Kristin Peck sits down with Jim Cramer
CNBC -
Examining The Growing Poultry Vaccine Market | Major Players Zoetis, Merck, Borhringer Ingelheim, Venkys
Mena FN -
Zoetis 1Q Revenue Edges Higher While Profit Slips
Morningstar 5/4/2023Zoetis logged a slimmer profit but slightly higher revenue in the first quarter as sales growth in its international business offset a small decline in its U.S. segment. The veterinary-drug maker ...
-
Zoetis Earnings: Lumpiness With Distributors Damped Companion Animal Segment Growth
Morningstar -
Zoetis Announces First Quarter 2023 Results
Joplin Globe -
Analyzing the Price-to-Earnings Ratio of Zoetis Inc. (ZTS)
newsheater
